Suppliers / Zhejiang Hisoar Pharmaceutical

Zhejiang Hisoar Pharmaceutical

China 67 employees Updated 9 July 2026

Zhejiang Hisoar Pharmaceutical is an API manufacturer based in China. It holds 4 active US drug master files and 2 valid CEPs across a filed portfolio of 4 molecules.

4
active US DMFs
2
valid CEPs
1
registered plants
0
filings across 0 regulators

Registered plants

Site FDA FEI
Taizhou, China Not on file

What they file, and where

Molecule Regulators Docs
Clindamycin SFDA (Saudi Arabia), US FDA 4
Amorolfine EDQM, SFDA (Saudi Arabia) 2
Flunixin Meglumine For Veterinary Use EDQM 1
Metoprolol US FDA 1

Also appears on these molecule pages

Clindamycin API Flunixin Meglumine For Veterinary Use API Metoprolol API

Questions about Zhejiang Hisoar Pharmaceutical

Does Zhejiang Hisoar Pharmaceutical hold a US DMF or a CEP?
Zhejiang Hisoar Pharmaceutical holds 4 active US drug master files and 2 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Zhejiang Hisoar Pharmaceutical manufacture?
1 registered site is on record, in China (Taizhou). Every site is listed on this page with the register it came from.
What does Zhejiang Hisoar Pharmaceutical make?
4 molecules are on record against Zhejiang Hisoar Pharmaceutical, including Clindamycin, Amorolfine, Flunixin Meglumine For Veterinary Use and Metoprolol. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Zhejiang Hisoar Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Apitoria Pharma shares 1 molecule Zydus Lifesciences shares 1 molecule Acs Dobfar shares 1 molecule Chongqing Carelife Pharmaceutical shares 1 molecule Unión Químico Farmacéutica shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability